Valeant Pharmaceuticals International (VRX) 70.58

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Valeant Pharmaceuticals International (VRX) 70.58 $VRX

Fitbit Upgraded; Valeant, Urban Outfitters Cut
at Investor's Business Daily - 2 hrs 21 mins ago
Wearable fitness-tracking device maker Fitbit (FIT) was upgraded Tuesday, while Starwood Hotels & Resorts (HOT) and Urban Outfitters (URBN) were downgraded. Fitbit was lifted to buy at Bank of America following last week's sell-off in reaction to...
NBL: 36.56 (-0.44), URBN: 21.14 (-1.53), FIT: 28.57 (-0.19), AR: 23.82 (-0.91), VRX: 70.58 (-2.74), HES: 60.18 (-1.66), CHK: 5.84 (-0.50), TAP: 94.74 (+0.86), MAR: 72.92 (-0.80), FIVE: 27.15 (-1.34), SWN: 10.89 (-0.77), HOT: 71.91 (-0.36)

Jim Cramer -- Valeant's Sales Struggles Mean Allergan Could Profit
at The Street - Tue Nov 17, 9:49AM CST
Analysts are concerned about Valeant Pharmaceuticals but that can only help Action Alerts PLUS holding Allergan, Cramer says.
AGN: 296.15 (-2.56), VRX: 70.58 (-2.74), KYTH: 74.98 (-0.01)

Clovis Blowup Conjures Bad Biotech Memories of ImClone Darkness
at The Street - Mon Nov 16, 11:20AM CST
The last thing the biotech industry needs today is another hit to investor credibility. Clovis isn't helping.
BLUE: 80.00 (+5.55), ZFGN: 14.61 (-0.11), BIIB: 279.89 (-3.64), VRX: 70.58 (-2.74), CLVS: 26.84 (-3.40), AZN: 33.35 (+0.57), FOLD: 9.30 (-0.83), CELG: 111.02 (+0.88)

10 Stocks That Have Made Julian Robertson's Tiger Cubs a Lot of Money
at The Street - Sun Nov 15, 5:00PM CST
Hedge fund legend Julian Roberts' disciples know how to pick 'em. These 10 stocks have been their biggest winners over the past decade.
AMZN: 643.35 (-4.46), VRX: 70.58 (-2.74), FB: 105.16 (+1.12), CHTR: 184.60 (-1.09), LNG: 47.91 (-2.04), PCLN: 1,254.46 (-12.41), NFLX: 115.92 (+4.57), BIDU: 196.24 (-2.48), TDG: 231.27 (+0.03), GOOGL: 746.86 (-3.56), FLT: 148.82 (+0.30), JD: 28.72 (-0.09), AAPL: 113.70 (-0.48), MA: 98.18 (-0.12)

5 Drugs That Are the Face of Prescription Drug Reform
Sean Williams, The Motley Fool - Motley Fool - Sun Nov 15, 8:41AM CST
Image source: Flickr user StockMonkeys.com. Think fast: what's the first thing that comes to mind when I say "prescription drugs?" Were you too busy reaching for your wallet to think of anything? Don't worry, you're probably not alone. ...
MNK: 57.39 (+0.17), VRX: 70.58 (-2.74), VRTX: 127.69 (+2.41), GILD: 104.52 (+0.71)

What an Old Bull Looks Like; A Technological Tidal Wave: Best of Kass
at The Street - Fri Nov 13, 8:00PM CST
In highlights from this week's trading diary and posts, Kass discusses why this bull market reminds him of himself, and why the tech transformation hitting retail is just the start.
WFM: 29.87 (-0.20), MNK: 57.39 (+0.17), AMZN: 643.35 (-4.46), VRX: 70.58 (-2.74), FB: 105.16 (+1.12), GM: 35.11 (-0.06), M: 37.89 (-0.73), CAT: 69.42 (-0.97)

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Valeant Pharmaceuticals International, Inc. of Class Action Lawsuit and Upcoming Deadline - VRX
GlobeNewswire - Fri Nov 13, 3:39PM CST
Pomerantz LLP announces that a class action lawsuit has been filed against Valeant Pharmaceuticals International Inc. ("Valeant" or the "Company" (NYSE:VRX) and certain of its officers. The class action, filed in United States District Court, District of New Jersey, is on behalf of a class consisting of all persons or entities who purchased Valeant securities between February 23, 2015 and October 20, 2015 inclusive (the "Class Period". This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act".
VRX: 70.57 (-2.75), VRX.TO: 93.99 (-3.80)

We're Not in a Bubble, It's Already Popped
at The Street - Fri Nov 13, 2:30PM CST
Some predict a looming crash, but many stocks have just had one.
AMZN: 643.35 (-4.46), GPRO: 20.84 (-0.78), VRX: 70.57 (-2.75), ABX: 7.03 (-0.60), VJET: 5.21 (-0.21), FB: 105.16 (+1.12), DDD: 8.66 (-0.15), GOOG: 725.65 (-3.31), BTU: 12.75 (-1.13), FOSL: 34.63 (+2.78), SUNE: 3.15 (-1.41), CHK: 5.84 (-0.50), SSYS: 22.53 (-0.46), GOOGL: 746.86 (-3.56), GDX: 13.15 (-0.59), AAPL: 113.70 (-0.48), GG: 11.43 (-0.62)

Why Concordia Healthcare Corp Is Shooting Higher Today
Brian Feroldi, The Motley Fool - Motley Fool - Fri Nov 13, 1:59PM CST
What: Shares of Concordia Healthcare , a Canadian-based pharmaceutical company, were up more than 15% in afternoon trading after the company reported third quarter earnings that impressed Wall Street. So what:  The company's growth by...
VRX: 70.58 (-2.74)

Trader's Notebook: Russell 2K ETF Drops 2%
at The Street - Fri Nov 13, 8:00AM CST
Bottom fishers in the IWM should keep an eye on its 50-day moving average.
VRX: 70.58 (-2.74), DIA: 175.09 (+0.07), IWM: 114.70 (-0.35)

Jim Cramer: Why the Fed Is the Stock Market’s Enemy Right Now
at The Street - Fri Nov 13, 5:10AM CST
With heighten speculation the Fed will raise rates in December, Cramer weighs in on why the Fed is the market's adversary.
AGN: 296.15 (-2.56), NFLX: 115.91 (+4.56), DHI: 31.40 (+0.01), AMZN: 643.35 (-4.46), VRX: 70.58 (-2.74), FB: 105.13 (+1.09), MCD: 110.98 (-0.08), STZ: 137.56 (+2.30), GOOGL: 746.86 (-3.56)

Nordstrom Adds to Retail Pain With Disappointing Earnings Results
at The Street - Fri Nov 13, 4:00AM CST
The CNBC 'Fast Money' traders examine stocks after a rough day of trading Thursday, before turning their attention to the struggling retail sector.
VRX: 70.58 (-2.74), HD: 125.54 (+4.70), SHAK: 42.79 (-0.63), NKE: 122.32 (-1.14), M: 37.89 (-0.73), UA: 84.95 (-5.05), SPY: 205.31 (-0.31), TJX: 67.96 (+2.31), ERIC: 9.49 (-0.05), SUNE: 3.15 (-1.41), CMG: 581.31 (-7.43), JWN: 54.37 (-0.36), MCD: 110.98 (-0.08), CSCO: 26.86 (+0.07)

Valeant Pharmaceuticals To Present At Industry Conference
CNW Group - Thu Nov 12, 7:00PM CST
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that members of its senior management team will be presenting at the Jefferies Autumn 2015 Global Healthcare Conference in London, UK.
VRX: 70.58 (-2.74), VRX.TO: 93.99 (-3.80)

Gilead, Regeneron Stocks Weather Drug Pricing Furor
at Investor's Business Daily - Thu Nov 12, 5:30PM CST
Recent weeks have not been friendly to the pharmaceutical industry, with some stocks in the sector such as Valeant Pharmaceuticals (VRX) and Horizon Pharma (HZNP) withering amid criticism over the industry's drug-pricing practices and fears of...
MNK: 57.39 (+0.17), ESRX: 84.10 (-0.56), VRX: 70.58 (-2.74), GILD: 104.52 (+0.71), HZNP: 18.59 (-0.37), SNY: 43.61 (+0.49), REGN: 570.36 (+11.98)

SmarTrend Watching for Potential Rebound in Shares of Valeant Pharmaceuticals International After 6.50% Loss
Comtex SmarTrend(R) - Thu Nov 12, 4:36PM CST
Valeant Pharmaceuticals International (NYSE:VRX) traded in a range yesterday that spanned from a low of $73.69 to a high of $77.00. Yesterday, the shares fell 6.5%, which took the trading range below the 3-day low of $78.60 on volume of 17.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
VRX: 70.58 (-2.74)

Horizon (HZNP) Slips, Comments on Express Scripts Charges
Zacks Equity Research - Zacks Investment Research - Thu Nov 12, 3:45PM CST
Horizon Pharma plc (HZNP) tumbled 19.6% after it commented on Express Scripts Holding Company's (ESRX) business practices.
VRX: 70.58 (-2.74), ESRX: 84.10 (-0.56), HZNP: 18.59 (-0.37)

Valeant (VRX) Stock Falls Further on Insider Trading Suit
at The Street - Thu Nov 12, 1:34PM CST
Valeant (VRX) stock is continuing yesterday's decline in afternoon trading on Thursday, after a judge ruled the company and Bill Ackman must face a shareholder lawsuit alleging insider trading.
VRX: 70.58 (-2.74)

Regeneron Recovers From Clinton Biotech Beat Down
at Investor's Business Daily - Thu Nov 12, 10:27AM CST
Biotech stocks and drugmakers like Valeant Pharmaceuticals (VRX) took a beating in September when Hillary Clinton accused Big Pharma of price gouging. But Regeneron Pharmaceuticals (REGN) has now bounced back into a buy zone. The New York-based...
VRX: 70.58 (-2.74), GILD: 104.52 (+0.71), AMGN: 157.76 (+3.26), SNY: 43.61 (+0.49), REGN: 570.36 (+11.98)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Joshua Davenport: Celebrating 25 Years in Healthcare

Updated Category News Views 1

25 Years Strong: Davenport's Journey in Healthcare Not every day you celebrate someone who's spent a quarter of a century in the trenches of healthcare. Joshua L. Davenport, RN, isn't just clocking years; he's built a legacy in emergency nursing and occupational health that speaks volumes about resilience and commitment to others. From Humble Beginnings to Health...

Continue Reading
Denarius Metals Unveils Technical Insight for Toral Project

Updated Category News Views 2

Denarius Metals Shares Tech Report on Toral Project It's a curious moment in the mining world when Denarius Metals decides to drop their latest gem—a technical report on the Toral Project. We're talking about a full-bodied document rooted in the stringent National Instrument 43-101 standards. This isn't some half-baked release; it's a robust assertion of where they...

Continue Reading
Hi3D Unlocks AI 3D Model for Open-Source Innovation

Updated Category News Views 6

A New Era in 3D Model Accessibility Unless you’ve been hiding under a rock, it’s hard to miss how digital terraforming has shifted gears. With Hi3D V1.0 opening its doors, the playing field's getting a major reshuffle. Or, as they say, the table is being set, and everyone's getting a seat. By letting loose production-validated AI tools, Hi3D is throwing down the...

Continue Reading
Better Home & Finance Faces Class Action: What's Next?

Updated Category News Views 3

Stock Hit and Legal Drama Panic set in when Better Home & Finance Holding Company took a 28.5% nosedive after spilling some less-than-sweet news. Their promise of hitting a billion in monthly loans? Stuck in limbo as borrower trepidation reared its ugly head amidst rising rates. Investors felt the heat, watching shares skydive $12.17, landing them at a bruised $30.52. A...

Continue Reading
FOX News Revamps 2026 Election Coverage Playbook

Updated Category News Views 2

Revamped Coverage: More Than Just Breaking News Yeah, everyone's clamoring about the midterms, but Fox News is doing more than just flipping on the camera and breaking the news every few minutes this year. They're rolling out the big guns: AI chatbots, flashy graphics, and special shows across multiple platforms. The point? To get viewers practically hooked and give 'em...

Continue Reading
Anavex Faces Securities Lawsuit: Investor Implications

Updated Category News Views 4

Storm Clouds Over Anavex: What Investors Need to Know If you've got a slice of Anavex Life Sciences Corp. (NASDAQ: AVXL) in your portfolio, the latest chapter of their legal saga feels less like a twist and more like a twist of the knife. These lawsuits often come out of left field for investors, but this one seems like a slow train that’s been gathering steam for a...

Continue Reading
Dimora Medical Boosts Advanced Wound Care at HS Conference

Updated Category News Views 3

Empowering the HS Community with Innovations Look, if you’ve walked a mile in someone else's shoes—particularly ones dealing with hidradenitis suppurativa (HS)—you’d know what a relentless grind managing those exuding wounds can be. Dimora Medical, known for navigating the tricky territory of wound care, threw its hat into the ring at the HS Connect Empower...

Continue Reading
Disorderly Magic: New Lithium Batteries Breakthrough

Updated Category News Views 4

Disorder in Structure: A Game-Changer? Lithium-ion batteries—yeah, the gizmos powering your fancy electric cars and gadgets—might have just hit their next big break, all thanks to a little chaos. Over in Chungcheong Province, South Korea, researchers at Hanbat National University are messing with the atomic structure of lithium-rich cathodes, and guess what? They're...

Continue Reading
MATIC S68 Wheels: A Bold Step for Superteam

Updated Category News Views 6

Premium Racing Takes a New Spin Scratch the surface of a tire-obsessed market, and you'll find Superteam Wheels making a calculated leap. Their new premium sub-brand, MATIC, isn't just fluff—it shows a serious attempt to impress those who’d rather cut corners on a track than a spreadsheet. Introducing the MATIC S68—buttery smooth, pitch-perfect, and undeniably...

Continue Reading
Lincoln Educational Faces Investor Lawsuit Over Revenue Drop

Updated Category News Views 3

Investors Face Rough Waters Okay, let’s dive into this latest mess at Lincoln Educational Services Corp. (NASDAQ:LINC). Things aren't smelling too rosy over at their headquarters. If you've got shares here, you’ll know what I mean. Back in early May, the folks running Lincoln threw a garden party talking up a 19.5% growth in student starts. Who wouldn’t get behind...

Continue Reading

Top 5 Most Recently Viewed Articles

M7 World Championship 2025: A New Era for Esports in Indonesia

Updated Category News Views 153

M7 World Championship 2025: A New Era for Esports in Indonesia The stage is set for the M7 World Championship—a monumental event poised to showcase Indonesia as a hub for global esports. This year, the championship promises to amplify the excitement surrounding Mobile Legends: Bang Bang (MLBB) Esports through a series of thrilling matches and vibrant cultural...

Continue Reading
James Hardie Industries Faces Class Action – Key Details Inside

Updated Category News Views 142

James Hardie Industries plc. Class Action Lawsuit Overview Investors in James Hardie Industries plc. (NYSE: JHX) are being alerted to an important class action lawsuit that is currently underway. This lawsuit aims to address concerns over alleged securities fraud that impacted shareholders. Understanding the Class Action Details The lawsuit's objective is to seek...

Continue Reading
Embla Medical Reports Impressive Growth in Q3 2024 Results

Updated Category News Views 152

Embla Medical Delivers Strong Q3 2024 Performance Sveinn Sölvason, President and CEO of Embla Medical hf, has shared positive updates regarding the company’s performance in the third quarter of 2024. With an impressive sales figure of USD 214 million, the company has demonstrated consistent organic growth of 7% compared to the same quarter in the previous year. Sales...

Continue Reading
Standex Invites Investors to Discuss Q1 Fiscal 2025 Updates

Updated Category News Views 188

Standex International Corporation Announces Investor Call Standex International Corporation (NYSE: SXI) has officially scheduled an important investors' conference call to discuss its first quarter fiscal 2025 financial results. This call is set for the morning and will also cover the recent acquisition of Amran Instrument Transformers and Narayan Powertech Pvt. Ltd....

Continue Reading
Douglas Elliman Welcomes New Executive: Key Financial Insights

Updated Category News Views 274

Douglas Elliman's New Appointment and Its Implications Douglas Elliman Inc. (NYSE:DOUG), a leading real estate agency, has officially announced a significant change in its executive team. This change comes as the company moves forward with a fresh strategy aimed at enhancing its market position. James Bryant Kirkland III has been appointed as the Executive Vice President,...

Continue Reading